Oaktop Capital Management II L.P. bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPN) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,221,048 shares of the construction company’s stock, valued at approximately $5,434,000. Aspen Aerogels comprises approximately 1.0% of Oaktop Capital Management II L.P.’s portfolio, making the stock its 14th largest holding. Oaktop Capital Management II L.P. owned 5.93% of Aspen Aerogels at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Ameriprise Financial Inc. raised its position in Aspen Aerogels by 13.4% in the 1st quarter. Ameriprise Financial Inc. now owns 1,002,566 shares of the construction company’s stock worth $4,161,000 after purchasing an additional 118,491 shares during the last quarter. Heartland Advisors Inc. raised its position in Aspen Aerogels by 8.2% in the 1st quarter. Heartland Advisors Inc. now owns 920,000 shares of the construction company’s stock worth $3,818,000 after purchasing an additional 70,000 shares during the last quarter. Tocqueville Asset Management L.P. raised its position in Aspen Aerogels by 1.1% in the 2nd quarter. Tocqueville Asset Management L.P. now owns 856,055 shares of the construction company’s stock worth $3,809,000 after purchasing an additional 9,400 shares during the last quarter. Royce & Associates LP raised its position in Aspen Aerogels by 41.6% in the 2nd quarter. Royce & Associates LP now owns 585,954 shares of the construction company’s stock worth $2,607,000 after purchasing an additional 172,030 shares during the last quarter. Finally, Renaissance Technologies LLC raised its position in Aspen Aerogels by 12.5% in the 1st quarter. Renaissance Technologies LLC now owns 262,500 shares of the construction company’s stock worth $1,089,000 after purchasing an additional 29,200 shares during the last quarter. Institutional investors own 74.41% of the company’s stock.
Shares of Aspen Aerogels, Inc. (ASPN) opened at 4.18 on Monday. Aspen Aerogels, Inc. has a 12-month low of $3.61 and a 12-month high of $6.71. The firm’s 50-day moving average is $4.41 and its 200-day moving average is $4.27. The firm’s market cap is $86.03 million.
Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Thursday, August 3rd. The construction company reported ($0.23) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.24) by $0.01. The firm had revenue of $25.10 million during the quarter, compared to the consensus estimate of $24.79 million. Aspen Aerogels had a negative net margin of 22.22% and a negative return on equity of 20.95%. The company’s revenue for the quarter was down 9.4% on a year-over-year basis. During the same quarter last year, the firm earned ($0.02) earnings per share. Analysts predict that Aspen Aerogels, Inc. will post ($0.86) earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Oaktop Capital Management II L.P. Takes $5.43 Million Position in Aspen Aerogels, Inc. (NYSE:ASPN)” was originally reported by BBNS and is the property of of BBNS. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://baseballnewssource.com/markets/oaktop-capital-management-ii-l-p-takes-position-in-aspen-aerogels-inc-aspn/1557059.html.
A number of research firms have commented on ASPN. Zacks Investment Research raised shares of Aspen Aerogels from a “hold” rating to a “buy” rating and set a $4.75 target price for the company in a report on Wednesday, August 23rd. ValuEngine lowered shares of Aspen Aerogels from a “sell” rating to a “strong sell” rating in a report on Friday, July 28th. Finally, Citigroup Inc. lifted their target price on shares of Aspen Aerogels from $4.50 to $4.75 and gave the stock a “neutral” rating in a report on Tuesday, May 30th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $6.38.
Aspen Aerogels Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
Receive News & Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related companies with our FREE daily email newsletter.